Skip to content
Skip to navigation
Skip to footer

Oncology

Our people

Home / Our company / Our people / Oncology

Our Oncology is focusing on some of the most hostile and hard-to-treat cancers. By understanding the complexities of cancer, we hope to achieve life-changing benefits for patients.

Alicyn Campbell

Head of Digital Health, Oncology R&D

Senior Vice President, Global Head of Haematology (Early and Late Stage) Oncology R&D

Vice President, Franchise Head, Late Oncology R&D

Cristian Massacesi

Chief Medical Officer and Oncology Chief Development Officer

Vice President of Early Development Oncology

Gemma Satterthwaite

Global Product Leader, Oncology Business Unit

Director, Translational Medicine, Oncology Research & Early Development

Head of Epigenetics, Research & Development

Ingrid A. Mayer

Global Clinical Head for Breast Cancer and Breast Cancer Strategy

Global Study Medical Scientist Leader, Immuno-oncology

Global Clinical Head for Lung Cancer and Lung Cancer Strategy

Director, Head of the Cancer Research UK – AstraZeneca Antibody Alliance Laboratory

Vice President, Discovery, Oncology R&D

Mark O’Connor

Chief Scientist, Early Oncology Discovery

Maurizio Scaltriti

Vice President, Translational Medicine, Early Oncology

Vice President and Franchise Head, R&D, AstraZeneca

VP, Late Stage Oncology Clinical Operations, AstraZeneca

VP, Global Franchise Head Lung Cancer, Oncology Business Unit

Senior Vice President, Biologics Engineering & Oncology Targeted Delivery

Senior Vice-President of Precision Medicine, R&D Oncology

Vice President, Oncology Business Unit

Senior Vice President, Global Head of Oncology, Medical, AstraZeneca

Susan Galbraith

Executive Vice-President, Oncology R&D

Teresa Klinowska

Global Product Leader, Oncology R&D

Vice President, International Oncology

Explore our people in other business units

BioPharmaceutical

Enabling Functions

Veeva ID: Z4-51286
Date of preparation: December 2022